Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • CRISTOFANILLI M
    • VERMA S
    • IWATA H
    • HARBECK N
    • ZHANG K
    • THEALL KP
    • JIANG Y
    • BARTLETT CH
    • KOEHLER M
    • SLAMON D
    • TURNER NC
    • BONDARENKO I
    • RO J
    • IM S-A
    • MASUDA N
    • COLLEONI M
    • DEMICHELE A
    • PROF Sherene Loi

Published in

  • Lancet Oncology

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(15)00613-0

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 17

Issue

  • 4

Publisher

  • Lancet